Zhang Yongfang, Xie Xinyi, Chen Boyu, Pan Lina, Li Jianping, Wang Wanbing, Wang Jintao, Tang Ran, Huang Qiang, Chen Xiaofen, Ren Rujing, Zhang Zhentao, Fu Wei, Wang Gang
Department of Neurology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Genes Dis. 2023 Apr 10;11(2):1022-1034. doi: 10.1016/j.gendis.2023.02.051. eCollection 2024 Mar.
Identified as the pathogenic genes of Alzheimer's disease (AD), , , mainly lead to early-onset AD, whose course is more aggressive, and atypical symptoms are more common than sporadic AD. Here, a novel missense mutation, E674Q (also named "Shanghai "), was detected in a Chinese index patient with typical late-onset AD (LOAD) who developed memory decline in his mid-70s. The results from neuroimaging were consistent with AD, where widespread amyloid β deposition was demonstrated in F-florbetapir Positron Emission Tomography (PET). E674Q is close to the β-secretase cleavage site and the well-studied Swedish mutation (KM670/671NL), which was predicted to be pathogenic . Molecular dynamics simulation indicated that the E674Q mutation resulted in a rearrangement of the interaction mode between APP and BACE1 and that the E674Q mutation was more prone to cleavage by BACE1. The results suggested that the E674Q mutation was pathogenic by facilitating the BACE1-mediated processing of APP and the production of Aβ. Furthermore, we applied an adeno-associated virus (AAV)-mediated transfer of the human E674Q mutant APP gene to the hippocampi of two-month-old C57Bl/6 J mice. AAV-E674Q-injected mice exhibited impaired learning behavior and increased pathological burden in the brain, implying that the E674Q mutation had a pathogenicity that bore a comparison with the classical Swedish mutation. Collectively, we report a strong amyloidogenic effect of the E674Q substitution in AD. To our knowledge, E674Q is the only pathogenic mutation within the amyloid processing sequence causing LOAD.
被确定为阿尔茨海默病(AD)的致病基因,主要导致早发性AD,其病程更具侵袭性,非典型症状比散发性AD更常见。在此,在一名典型晚发性AD(LOAD)的中国索引患者中检测到一种新的错义突变E674Q(也称为“上海”),该患者在70多岁时出现记忆衰退。神经影像学结果与AD一致,在F-氟代苯丙氨酸正电子发射断层扫描(PET)中显示广泛的淀粉样β沉积。E674Q靠近β-分泌酶切割位点和经过充分研究的瑞典突变(KM670/671NL),预计具有致病性。分子动力学模拟表明,E674Q突变导致APP与BACE1之间的相互作用模式发生重排,并且E674Q突变更容易被BACE1切割。结果表明,E674Q突变通过促进BACE1介导的APP加工和Aβ的产生而具有致病性。此外,我们将人E674Q突变体APP基因通过腺相关病毒(AAV)介导转移到两个月大的C57Bl/6J小鼠的海马中。注射AAV-E674Q的小鼠表现出学习行为受损和大脑中病理负担增加,这意味着E674Q突变具有与经典瑞典突变相当的致病性。总体而言,我们报告了E674Q替代在AD中具有强烈的淀粉样蛋白生成作用。据我们所知,E674Q是淀粉样蛋白加工序列中导致LOAD的唯一致病突变。